U

Imagin Medical Inc. IMEXF

$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Imagin Medical Inc. is a Canadian medical technology company focused on developing imaging technologies for minimally invasive surgical and diagnostic procedures, particularly in urology and bladder cancer detection. The company has primarily operated within the medical device and healthcare technology sectors, with its core development effort centered on the i/Blue Imaging System, a platform designed to improve visualization during cystoscopic procedures by integrating white-light and blue-light imaging capabilities. Public disclosures indicate that the company’s strategy has focused on enhancing diagnostic accuracy and procedural efficiency for physicians treating non-muscle invasive bladder cancer.

The company historically positioned itself as an emerging developer of advanced imaging systems intended to compete in a specialized segment of the endoscopy and surgical visualization market. Its business model has largely been research-and-development driven rather than revenue-scale commercial operations. Based on available public filings and market disclosures, Imagin Medical evolved from an early-stage medical technology venture into a company seeking commercialization partnerships, regulatory progress, and strategic financing to support product development. Certain historical operational details and commercialization milestones remain limited in publicly available records, and some data is inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Tuesday, August 29, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)

Price History

Loading...
52-Week Range0% of range
Low
$0.00
Current
$0.00
High
$0.00
Beta
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
--
Address
890 West Pender Street
Suite 600
Vancouver, BC V6C 1L9
Country
Year Founded
--

Headlines

There are no news to display.